The pill received FDA approval earlier this year but saw very low sales within its first month on the market.
The CEO of Sprout Pharmaceuticals, the company behind the "female Viagra" drug that received FDA approval earlier this year, is reportedly leaving the company. "I feel like I've seen it through to what I wanted to accomplish," Cindy Whitehead said in an interview with Bizwomen. "It really was to prove the science, get the approval so that women could have this choice for themselves and then really to build the team to have it really come to the realization of the bigger mission, which is the opportunity for this to go global and to be made widely available to women in an affordable way."
